Key Dates

Related Announcements

• July 12, 2023 - SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed). See NOFO PAR-23-219.
• July 12, 2023 - SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Required). See NOFO PAR-23-220.
• November 23, 2020 - Notice of Clarification of SB1 Resubmission/Submission Policy. See Notice NOT-OD-21-027.
• July 23, 2018 - NIH/AHRQ Application Submission/Resubmission Policy. See Notice NOT-OD-18-197.

Issued by

NATIONAL INSTITUTES OF HEALTH (NIH)

Purpose

The purpose of this Notice is to rescind NOT-OD-21-027 "Notice of Clarification of SB1 Resubmission/Submission Policy".

Due to changes in allowable application types, the previous limitations on resubmission applications to the SBIR/STTR Commercialization Readiness Pilot (CRP) Program no longer apply. Eligible applicants that have had an active NIH SBIR or STTR Phase II or IIB award within the last 36 months may submit a “New” A0 application via PAR-23-219 or PAR-23-220 (and subsequent reissued NOFOs) following an unsuccessful A0 or resubmission A1 application.

All other aspects of CRP NOFOs remain the same. Only one CRP award is allowed per Phase II or Phase IIB project. A project that is awarded a CRP during or after the Phase II cannot be awarded an additional CRP during or after the Phase IIB.

Inquiries

Please direct all inquiries to:

SEED (Small business Education and Entrepreneurial Development)
Office of Extramural Research
Email: [email protected]